No Data
No Data
Syoung Group (300740.SZ): As of June 20th, there are over 16,000 shareholders in the company.
On June 21, Gelunhui reported that as of June 20, Syoung Group (300740.SZ) stated on the investor interaction platform that the total number of shareholders in the company exceeded 16,000.
Syoung Group (300740.SZ): In 2023, the equity will be distributed with a dividend of 1 yuan per share, and the registration date is June 17.
On June 11th, Gelunhui reported that Shuiyang Group (300740.SZ) announced that the equity distribution plan for the year 2023 is: based on the total share capital on the registration date of equity distribution implemented by the company (as of June 10, 2024, the total share capital was 388,676,998 shares), and each shareholder will receive a cash dividend of RMB 1 per 10 shares (including tax). The equity distribution registration day for this distribution is June 17, 2024, and the day the equity rights and interests will be removed is June 18, 2024.
SYoung Group Co., Ltd.'s (SZSE:300740) Stock Has Fared Decently: Is the Market Following Strong Financials?
SYoung Group's (SZSE:300740) stock is up by 9.0% over the past three months. Since the market usually pay for a company's long-term financial health, we decided to study the company's fundamentals t
Shuiyang Co., Ltd. (300740.SZ): The Yumifang brand currently focuses on comprehensive brand upgrading to complete mental correction, grooming and product system iteration
Gelonghui, May 10 | Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that the Yunifang brand is currently focusing on comprehensive brand upgrading to complete mental correction and product system iteration. On May 9, 2024, a press conference on the new upgrade of the brand “2+3 Oriental Skin Formula” was held, and a new big product, the “Black Ginseng Collagen Bottle”, was launched. Stay tuned for more details on the upgrade, and stay tuned for official news from the official Yunifang account, flagship store, etc.
Shuiyang Co., Ltd. (300740.SZ): AI technology has been used to assist in handling after-sales issues such as ownership, evaluation labeling, etc.
Gelonghui, May 10, 丨 Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that the company has not yet connected to the KIMI system and currently mainly uses GPT4. In terms of solving after-sales problems, AI technology has been used to assist in handling matters such as the attribution of after-sales issues, evaluation labels, etc.
Shuyang Co., Ltd. (300740.SZ): The tetrahydropyrimidine (ecdoine) strain developed in collaboration with Jiangnan University can be mass-produced
Gelonghui, May 10 | Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that in the field of synthetic biology, the company cooperated with Academician Chen Jian of Jiangnan University earlier and hired Academician Chen Jian as the chief scientist in 2022, and has obtained 11 patented technologies. Among them, Jiangnan University transferred 6 patents related to the use of synthetic biology to produce small-molecule hyaluronic acid, independently developed and obtained 5 patents for raw material preparation, testing and application, and applied the relevant technology to products such as Yunifang micro 800 and micro 400 hyaluronic acid subserums. Furthermore, tetrahydropyrimidine developed in collaboration with Kangnam University (Ike
No Data